INTERNATIONAL SOCIETY FOR EXTRACELLULAR VESICLES INC (EIN 462263206) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

STEPHANIE BRUNO

Phone

8564237222

Tax Period

2024-01-01 to 2024-12-31

INTERNATIONAL SOCIETY FOR EXTRACELLULAR VESICLES INC, founded in 2013, is a community nonprofit in the Science & Technology sector that reported $2.0M in total revenue in fiscal year 2024. Revenue grew 14% year-over-year, indicating healthy expansion. Expenses of $1.9M left a modest 4% surplus.

Mission

ADVANCE EXTRACELLULAR VESICLE RESEARCH AND THE UNDERSTANDING OF EXTRACELLULAR VESICLE BIOLOGY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $1,535,965

Investment Income $53,227

Other Revenue $411,053

TOTAL REVENUE $2,000,245

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $1,487,699

Other Expenses $1,916,455

TOTAL EXPENSES $1,916,455

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,000,245	$1,758,520	+0.1%
Expenses	$1,916,455	$1,462,135	+0.3%
Net Income	$83,790	$296,385	-0.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KEN WITWER	PRESIDENT	1.00	Officer Director	$0	$0	$0
BENEDETTA BUSSOLATI	PRESIDENT ELECT	1.00	Officer Director	$0	$0	$0
DEBORAH GOBERDHAN	SECRETARY GENERAL	1.00	Officer Director	$0	$0	$0
SURESH MATHIVANAN	TREASURER	1.00	Officer Director	$0	$0	$0
ANA CLAUDIA TORRECILHAS	EXEC. CHAIR-COMMUNICATION	1.00	Officer Director	$0	$0	$0
RANDY CARNEY	EXEC. CHAIR-EDUCATION	1.00	Officer Director	$0	$0	$0
ANDREAS MOLLER	EXEC. CHAIR-MEETINGS	1.00	Officer Director	$0	$0	$0
JUAN FALCON PEREZ	EXEC. CHAIR-TRANSLATION	1.00	Officer Director	$0	$0	$0
EDIT BUZAS	PAST PRESIDENT	1.00	Officer Director	$0	$0	$0
NAVEED AKBAR	DIRECTOR	1.00	Director	$0	$0	$0
DYLAN BURGER	DIRECTOR	1.00	Director	$0	$0	$0
YOUNG-EUN CHO	DIRECTOR	1.00	Director	$0	$0	$0
TOM DRIEDONKS	DIRECTOR	1.00	Director	$0	$0	$0
YU FUJITA	DIRECTOR	1.00	Director	$0	$0	$0
AN HENDRIX	DIRECTOR	1.00	Director	$0	$0	$0
NICOLE NOREN HOOTEN	DIRECTOR	1.00	Director	$0	$0	$0
YIYAO HUANG	DIRECTOR	1.00	Director	$0	$0	$0
MY MAHONEY	DIRECTOR	1.00	Director	$0	$0	$0
SUJATA MOHANTY	DIRECTOR	1.00	Director	$0	$0	$0
CARLOS SALOMON	DIRECTOR	1.00	Director	$0	$0	$0
SARA VEIGA	DIRECTOR	1.00	Director	$0	$0	$0
ANDREA TAYLOR	EXECUTIVE DIRECTOR (TMG)	20.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,000,245	$1,916,455	$2,684,025	$83,790
2023	$1,758,520	$1,462,135	$2,518,338	$296,385
2022	$1,891,061	$1,660,564	$1,935,084	$230,497
2021	$964,731	$614,334	$2,022,454	$350,397
2020	$887,161	$505,714	$1,565,996	$381,447

INTERNATIONAL SOCIETY FOR EXTRACELLULAR VESICLES INC